What amount sold does EPOCH Epigenetics, Inc. report in Form D filings?

The latest linked filings report $73K sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was EPOCH Epigenetics, Inc.'s most recent SEC filing?

EPOCH Epigenetics, Inc.'s most recent Form D filing was on 2025-06-16.

How many investors does EPOCH Epigenetics, Inc. have?

The most recent Form D filing lists 1 investor(s).

What type of securities does EPOCH Epigenetics, Inc. offer?

EPOCH Epigenetics, Inc.'s SEC Form D filings indicate debt offerings.

EPOCH Epigenetics, Inc.

CIK: 0002068186·Biotechnology·BALTIMORE, MD·Corporation·Founded 2023

Reported Sold

$72,500

Total Filings

Identified Offerings

Last Filed

Jun 16, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Jun 16, 2025Form D — New notice

Reported sold: $72,500 · Target: $3,000,000

Rule 506(b)·1 investor

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$72,500

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Joseph Swiader

Related Person

Appears on 1 filing

Eric Van Gieson

Related Person

Appears on 1 filing

Neil Hermansen

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jun 16, 2025	New	$3,000,000	$72,500	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Accufy Diagnostics, Inc.

Biotechnology

Offering target: $2,000,000

Filed Oct 28, 2026